From: Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion: a randomized, controlled clinical trial
AKI is defined as any of the following (not graded):
- Increase in SCr by ≥ 0.3 mg/dl within 48 h
- Increase in SCr to ≥ 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days